Eroles P

No ORCID on file · 1 paper in corpus

2026

TROP2-targeting antibody-drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms.

Cancer drug resistance (Alhambra, Calif.) ·doi:10.20517/cdr.2025.195

Antibody-drug conjugates (ADCs) targeting trophoblast cell-surface antigen 2 (TROP2) have emerged as a promising therapeutic strategy for the treatment of triple-negative breast cancer (TNBC) and ovarian carcinoma, two malignancies characte…